Holen Sie sich die Stockscreener-App
38.12
3.73%
1.37
Finanzdaten der Vtv Therapeutics Inc-Aktie (VTVT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | 0.017 |
Operating Expenses
|
26.30%
7.885
|
10.70 | 7.721 | 6.503 | 4.909 |
| Operating Income/Loss |
26.30%
-7.885
|
-10.70 | -7.721 | -6.503 | -4.892 |
| Income/Loss From Continuing Operations Before Tax |
31.00%
-7.138
|
-10.35 | -7.38 | -6.217 | -4.437 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
31.00%
-7.138
|
-10.35 | -7.38 | -6.217 | -4.437 |
|
Net Income/Loss
|
31.00%
-7.138
|
-10.35 | -7.38 | -6.217 | -4.437 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
100.00%
-
|
-1.647 | -1.334 | -1.125 | -0.803 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.19%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):